Ivacaftor deuterated
N/A
Report date: 2025/08/20 20:01:27
NME
Base Information
Drug NameIvacaftor deuterated
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesConcert Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesConcert Pharmaceuticals IncVertex Pharmaceuticals Incorporated
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A